Li, Xia; Bellotti, Renato; Meier, Gabriel; Bachtiary, Barbara; Weber, Damien; Lomax, Antony; Buhmann, Joachim; Zhang, Ye (2024). Uncertainty-aware MR-based CT synthesis for robust proton therapy planning of brain tumour. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 191(110056), p. 110056. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2023.110056
|
Text
1-s2.0-S0167814023093635-main.pdf - Accepted Version Available under License Creative Commons: Attribution (CC-BY). Download (4MB) | Preview |
BACKGROUND AND PURPOSE
Deep learning techniques excel in MR-based CT synthesis, but missing uncertainty prediction limits its clinical use in proton therapy. We developed an uncertainty-aware framework and evaluated its efficiency in robust proton planning.
MATERIALS AND METHODS
A conditional generative-adversarial network was trained on 64 brain tumour patients with paired MR-CT images to generate synthetic CTs (sCT) from combined T1-T2 MRs of three orthogonal planes. A Bayesian neural network predicts Laplacian distributions for all voxels with parameters (μ, b). A robust proton plan was optimized using three sCTs of μ and μ±b. The dosimetric differences between the plan from sCT (sPlan) and the recalculated plan (rPlan) on planning CT (pCT) were quantified for each patient. The uncertainty-aware robust plan was compared to conventional robust (global ±3%) and non-robust plans.
RESULTS
In 8-fold cross-validation, sCT-pCT image differences (Mean-Absolute-Error) were 80.84±9.84HU (body), 35.78±6.07HU (soft tissues) and 221.88±31.69HU (bones), with Dice scores of 90.33±2.43%, 95.13±0.80%, and 85.53±4.16%, respectively. The uncertainty distribution positively correlated with absolute prediction error (Correlation Coefficient: 0.62±0.01). The uncertainty-conditioned robust optimisation improved the rPlan-sPlan agreement, e.g., D95 absolute difference (CTV) was 1.10±1.24% compared to conventional (1.64±2.71%) and non-robust (2.08±2.96 %) optimisation. This trend was consistent across all target and organs-at-risk indexes.
CONCLUSION
The enhanced framework incorporates 3D uncertainty prediction and generates high-quality sCTs from MR images. The framework also facilitates conditioned robust optimisation, bolstering proton plan robustness against network prediction errors. The innovative feature of uncertainty visualisation and robust analyses contribute to evaluating sCT clinical utility for individual patients.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Weber, Damien Charles |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1879-0887 |
Publisher: |
Elsevier Scientific Publ. Ireland |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
18 Dec 2023 11:03 |
Last Modified: |
23 Feb 2024 00:14 |
Publisher DOI: |
10.1016/j.radonc.2023.110056 |
PubMed ID: |
38104781 |
Uncontrolled Keywords: |
Brain Tumours MR-based CT Synthesis Proton Therapy Robust Planning Uncertainty Estimation |
BORIS DOI: |
10.48350/190451 |
URI: |
https://boris.unibe.ch/id/eprint/190451 |